These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Mitomycin C and 5-fluorouracil as second choice treatment in advanced breast cancer patients.
    Author: Ardizzoni A, Pronzato P, Conte PF, Rosso R.
    Journal: Chemioterapia; 1984 Apr; 3(2):83-5. PubMed ID: 6442624.
    Abstract:
    Twenty-six patients with advanced breast cancer, (12 previously treated with adriamycin-containing regimens, 14 not exposed to adriamycin because of poor cardiac performance), were treated with combination chemotherapy including mitomycin C plus 5-fluorouracil. Objective response was seen in 7/66 patients (26.9%) with a statistically higher response rate in patients with fewer than 2 metastatic sites. Because of mild toxicity this regimen can be safely used as second-line chemotherapy for heavily pretreated patients and as first-line treatment in patients with poor cardiac performance.
    [Abstract] [Full Text] [Related] [New Search]